National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

yttrium Y 90 monoclonal antibody B3
A radioimmunoconjugate of monoclonal antibody (MoAb) B3 conjugated with isotope yttrium 90. MoAb B3 is a murine MoAb that recognizes a Lewis Y carbohydrate antigen present on the surface of many carcinomas. This radioimmunoconjugate emits beta particles that causes cytotoxicity in tumor cells and has both diagnostic and therapeutic uses. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:90 Y-B3
MOAB B3, yttrium Y 90
Y 90 monoclonal antibody B3
Abbreviation:Y90-B3



Previous:yttrium Y 90 DOTA monoclonal antibody HuAFP31, yttrium Y 90 DOTA monoclonal antibody HuPAM4, yttrium Y 90 glass microspheres, yttrium Y 90 humanized epratuzumab, yttrium Y 90 ibritumomab tiuxetan
Next:yttrium Y 90 monoclonal antibody BrE-3, yttrium Y 90 monoclonal antibody Hu3S193, yttrium Y 90 monoclonal antibody MN-14, yttrium Y 90 resin microspheres, yttrium Y 90-DOTA-chimeric monoclonal antibody cG250

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov